Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

@article{Murtola2007CholesterolloweringDA,
  title={Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.},
  author={Teemu J Murtola and Teuvo L. J. Tammela and Jorma Lahtela and Anssi Auvinen},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2007},
  volume={16 11},
  pages={2226-32}
}
BACKGROUND Previous studies have shown that statin use may reduce prostate cancer risk. In the current study, we evaluated the association between serum cholesterol-lowering medication use and prostate cancer risk at the population level. MATERIALS AND METHODS All newly diagnosed prostate cancer cases in Finland during 1995 to 2002 and matched controls (24,723 case control pairs) were identified from the Finnish Cancer Registry and the Population Register Center, respectively. Detailed… CONTINUE READING